TC BioPharm Holdings is a biotechnology business based in the US. TC BioPharm Holdings shares (TCBP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.60 – a decrease of 35.38% over the previous week. TC BioPharm Holdings employs 41 staff and has a trailing 12-month revenue of around $2.9 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.60 |
|---|---|
| 52-week range | $0.56 - $138.00 |
| 50-day moving average | $4.06 |
| 200-day moving average | $9.03 |
| Wall St. target price | $140.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-192.53 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.611 from 2024-11-18
| 1 week (2024-11-13) | -33.68% |
|---|---|
| 1 month (2024-10-18) | -87.92% |
| 3 months (2024-08-20) | -86.92% |
| 6 months (2024-05-20) | -44.45% |
| 1 year (2023-11-20) | 17.50% |
|---|---|
| 2 years (2022-11-18) | -99.96% |
| 3 years (2021-11-17) | N/A |
| 5 years (2019-11-17) | N/A |
| Revenue TTM | $2.9 million |
|---|---|
| Gross profit TTM | $3.8 million |
| Return on assets TTM | -108.92% |
| Return on equity TTM | -1217.48% |
| Profit margin | 0% |
| Book value | $3.38 |
| Market Capitalization | $378,677 |
TTM: trailing 12 months
We're not expecting TC BioPharm Holdings to pay a dividend over the next 12 months.
You may also wish to consider:
TC BioPharm Holdings's shares were split on a 1:10 basis on 4 August 2024 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your TC BioPharm Holdings shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for TC BioPharm Holdings shares which in turn could have impacted TC BioPharm Holdings's share price.
Over the last 12 months, TC BioPharm Holdings's shares have ranged in value from as little as $0.5574 up to $138. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while TC BioPharm Holdings's is 0.249. This would suggest that TC BioPharm Holdings's shares are less volatile than average (for this exchange).
To put TC BioPharm Holdings's beta into context you can compare it against those of similar companies.
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom. .
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.